NCDconnect

Antidiabetic medicine procurement often faces fragmentation, high MOQs, and long lead times. At NCDconnect, we streamline sourcing and supply chains by keeping high-demand medicines in stock, including Metformin, Glibenclamide, Gliclazide, and various human and analogue insulins. While having antidiabetics in stock doesn't solve all issues, it bridges a crucial gap, ensuring timely delivery to patients in low- and middle-income countries. Significant progress is being made, and we want to recognise and appreciate our partners's achievements in this space: Access to Medicine Foundation, David Beran, Health Action International, James Reid, The Helmsley Charitable Trust, Tinotenda Dzikiti, and many others 🙌 Share this with your network who would benefit from accessing these much needed medicines. And register today to ensure smooth and on-time delivery to patients. #NonCommunicableDisease #Antidiabetics #Diabetes #Insulin #Metformin #DiabetesManagement

A recent study by Médecins Sans Frontières (MSF) highlighted significant markups on diabetes medicines and insulin pens, raising concerns about accessibility and affordability worldwide. Key Findings: 1️⃣ GLP-1 medicines: 🔸 GLP-1 medicines like Ozempic & Trulicity have a staggering 39,562% markup in the US. 🔸 Not included in WHO recommendations, making them virtually unavailable in low- and middle-income countries. 🔸 Urgent need for policy action to ensure accessibility globally. 2️⃣ Insulin Pen Costing: 🔸 Preferred by users for ease, accuracy, and reduced stigma. 🔸 High prices limit access in low- and middle-income countries. 🔸 Insulin pens could be 30% cheaper than vials and syringes. Implications & Call to Action: 🔹 Over 537M globally are affected by diabetes, with rising cases in low-income regions. 🔹 Only half of those in need have access to insulin. 🔹 Urgent need for transparency and accountability in price-mark ups in the supply chain! This study underscores the importance of equitable access to essential medicines. Our team NCDconnect is proud to be joining the conversation to bring solutions — through partnership — for affordable healthcare worldwide. For the full article: https://lnkd.in/eGjH6eDm #Diabetes #HealthcareEquity #AffordableMedicine #MSFResearch #GlobalHealthcare #Antidiabetics

📢 Only 2 months left until the World Cancer Congress (WCC)! Hosted by Union for International Cancer Control (UICC), the WCC is a premier event uniting global health professionals to discuss and collaborate on the fight against cancer. We’re thrilled to announce that the NCDconnect team will be actively participating with a panel session on "Disparities in Cancer Care: Practical Approaches to Improve Global Access to Quality-Assured Cancer Medicines"! We’re excited to engage with fellow attendees, share our insights, and learn from the best in the field. Are you attending the WCC? We’d love to connect! Comment below or send us a message to arrange a meet-up and explore potential collaborations. 👉 https://lnkd.in/eZ8z4ux9 See you in Geneva! #WCC2024 #WorldCancerCongress #NCDconnect #HealthForAll #CancerResearch #GlobalHealth

📑 Unlocking Access to NCD Medicines: The Power of Voluntary Licensing There is a significant opportunity for voluntary licensing (VL) in the realm of non-communicable diseases (#NCDs). Despite a common misconception, non-originators and originators can work together in a healthy relationship, ultimately benefiting patients in a Win-Win-Win Situation. Key Insights: 🔷 Market Potential & Patient Reach: VL allows non-originators to expand patient reach without cannibalising originator sales. Originator sales continue to grow even after non-originator products enter the market, reaching new patient segments and territories. 🔷 Boost in New Medicines Approval: Increased patient diversity through licensing helps generate valuable Real-World Evidence (#RWE), aiding in new medicine approvals by National Regulatory Agencies (NRAs). 🔷 Financial incentives: Sustainable Licensing Bonds (SLBs) offer lower interest rates, therefore contributing to borrowing costs reduction for biopharmaceutical companies. 🔷 Market Shaping: Introducing a medicine in the market can positively impact the entrance of future medicines in the market due to existing infrastructure, manufacturing facilities and supply chain capabilities. 👉 Read the Medicines Patent Pool's full report here: Voluntary Licensing: https://lnkd.in/ebrrpAqU NCDconnect supports initiatives that leverage voluntary licensing to increase the availability and affordability of NCD medicines. By fostering healthy partnerships and addressing market needs, we aim to drastically scale patient reach and improve health outcomes worldwide. Together, let's make Universal Health Coverage a reality. #GlobalHealth #NCDconnect #HealthForAll #VoluntaryLicensing #AccessToMedicines #UHC #HealthcareInnovation #PatientReach #ESG

Welcome to our newest team member 🌐💙  👉 For Gauri Sahasrabudhe's full interview, click here: https://lnkd.in/efUP_agn #GlobalHealth #ProcurementInnovation #MeetTheTeam #noncommunicablediseases #NCDconnect 

🌍 World Population Day: Celebrating Life and Well-being On this World Population Day, we celebrate life around the world and reflect on the vital importance of achieving health equity for all. Imagine a world where everyone has the opportunity to live a long, healthy life. By working together and ensuring access to essential NCD medicines and medical supplies, we can: 🔹 Extend Life Expectancy: Focus on preventive care and access to essential medicines to help everyone lead a longer, healthier life. 🔹 Improve Livelihoods: Empower healthier populations to pursue their dreams, contribute to their communities, and build stronger economies. 🔹 Ensure Health Equity: Provide every individual, regardless of their background or location, with the care they need. Today, let's unite in our efforts to bridge the gap in access to NCD medicines and enhance the quality of life for all populations. #WorldPopulationDay #HealthForAll #LifeExpectancy #NCDconnect #GlobalHealth #EquityForAll

🌐 Public Financial Management as a Path to Universal Health Coverage 🌐 UHC is a human right and a central goal of #NCDconnect & IDA Foundation! A recent study analysed the interplay of devolution, health financing, and public financial management (PFM) in low- and middle-income countries (#LMICs), offering insights on advancing toward universal health coverage (#UHC). Key Insights: 🔍 Primary Health Care: Subnational governments play a critical role in service delivery. 🔍 Dependence on Central Funding: Subnational governments rely heavily on funding from the central level. In Uganda, 100% of district health budget is through transfers from the central level! 🔍 Expenditure Management: Delays and complex, cumbersome administrative procedures disrupt subnational expenditure (leading to inefficient spending, and inconsistent supply). 🔍 Strategic Purchasing: Devolution can promote strategic purchasing, as local authorities have more knowledge about local needs. However, strict line-item budgets limit their ability to purchase strategically. How to improve? 💡 Boost local health budgets and ensure return on health impact with conditional grants to subnational levels. 💡 Improve budgeting capacity and coordination. 💡 Simplify approval processes with digital systems. 💡 Shift to strategic purchasing where subnational governments have spending authority to shift to output-oriented payment methods (directly linked to health needs and provider performance). Find the full article here & leave your thoughts below: https://lnkd.in/e8ZP55DG By addressing these challenges, we can better align resources and needs, ultimately enhancing health outcomes and moving closer to #UHC. #HealthCare #PublicHealth #HealthFinancing #Devolution #UniversalHealthCoverage #GlobalHealth #LMICs #HealthSystems #PublicFinance #NCDconnect

For governments, civil societies, and international organizations, tackling Non-Communicable Diseases and mental health challenges is a major undertaking. Multisectoral collaboration is essential! Want to learn from real-world experiences? Discover insightful tools and key lessons from the World Health Organization's Compendium report, demonstrating how multisectoral efforts are crucial in addressing NCDs and mental health issues. #GlobalHealth #NCDs #MentalHealth #WHO #HealthForAll

🎉 NCDconnect is celebrating its 6-month anniversary! Here's a glance at our journey and swipe for more 👇 ✨What we've accomplished? A strong one-stop shop for NCD procurement, offering 67 oncology medicines, 25 anti-diabetics, and 19 diagnostics. Thanks to a strong ecosystem approach and pivotal partnerships with ATOM (Union for International Cancer Control (UICC)), FIND and Coalition for Access to NCD Medicines & Products.  🌐 Looking ahead, the future is bright and bustling with promises: expanding diagnostics, launching cardiovascular and respiratory products, and forging more strategic partnerships. As we continue this journey, our mission remains steadfast—to contribute to a healthier world by enhancing accessibility to essential NCD health products. #NCDconnect #HealthForAll #AccessToMedicines #ProcurementInnovation 💙

Our very own Eghosasere Ramnaps was at the QUAMED asbl 2024 General Assembly last week. 💡 It was an invaluable opportunity for NCDconnect to engage, share our progress, and learn from global health stakeholders committed to ensuring access to quality medicines for all. Here are four key takeaways from the event: 1️⃣ Continuous Capacity Development: Institutional and individual capacity development across the medicine life cycle is critical for securing quality health products. QUAMED supports this through educational opportunities for individuals via QUAMED Learning and for institutions via the Quality Compliance Program (QCP). 2️⃣ Collaborative Efforts: No single organisation can solve the issue of poor-quality medicines alone. Coordination, collaboration, and partnerships are essential. 3️⃣ Regulatory System Strengthening: Strengthening regulatory systems is crucial for accessing quality health products. The WHO Global Benchmarking Tool exemplifies capacity-building by categorizing systems into maturity levels. Ensuring quality medicines also requires GMP, GSDP, and MQAS audits, supplier vetting, market assessments, compliance with GSDP, and robust pharmacovigilance. 4️⃣ Policy as a Driver: Strong QA policies are vital for ensuring that only quality medicines are manufactured, procured, and distributed. 🗨 Let’s keep the conversation going and maintain high standards for quality medicines worldwide!   Want to learn more about NCDconnect and IDA Foundation’s QA commitments? https://lnkd.in/e5Ks7F-e  #GlobalHealth #QualityMedicines #pharmacovigilance #QualityAssurance #HealthForAll